These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 12727967)

  • 21. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis.
    Sedivá A; Bartůnková J; Kolárová I; Hrusák O; Vávrová V; Macek M; Lockwood CM; Dunn AC
    J Autoimmun; 1998 Apr; 11(2):185-90. PubMed ID: 9650098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioiodine therapy versus antithyroid medications for Graves' disease.
    Ma C; Xie J; Wang H; Li J; Chen S
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
    Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
    Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment.
    Yazisiz V; Ongüt G; Terzioğlu E; Karayalçin U
    Int J Clin Pract; 2010 Jan; 64(1):19-24. PubMed ID: 18284438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism.
    Calhan T; Senateş E; Cebeci E; Zuhur SS; Ozbakır F; Görpe U
    Endocrine; 2010 Oct; 38(2):199-205. PubMed ID: 21046481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study.
    Slot MC; Links TP; Stegeman CA; Tervaert JW
    Arthritis Rheum; 2005 Feb; 53(1):108-13. PubMed ID: 15696557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study.
    Ooi CJ; Lim BL; Cheong WK; Ling AE; Ng HS
    Ann Acad Med Singap; 2000 Nov; 29(6):704-7. PubMed ID: 11269973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.
    Ruffatti A; Sinico RA; Radice A; Ossi E; Cozzi F; Tonello M; Grypiotis P; Todesco S
    J Rheumatol; 2002 May; 29(5):918-23. PubMed ID: 12022350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
    Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
    Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antineutrophil cytoplasmic antibodies in patients treated with methimazole: a prospective Brazilian study.
    Andrade GC; Maia FCP; Mourão GF; Rosario PW; Calsolari MR
    Braz J Otorhinolaryngol; 2019; 85(5):636-641. PubMed ID: 30057255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.
    Benker G; Reinwein D; Kahaly G; Tegler L; Alexander WD; Fassbinder J; Hirche H
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):451-7. PubMed ID: 9876342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ANCA in Graves' disease--is it antithyroid medication-induced?
    Prakash EB
    J Assoc Physicians India; 2009 Jul; 57():545; author reply 545. PubMed ID: 20329422
    [No Abstract]   [Full Text] [Related]  

  • 39. The significance of antithyroglobulin and antithyroidal microsomal antibodies in patients with hyperthyroidism due to Graves' disease treated with antithyroidal drugs.
    Takaichi Y; Tamai H; Honda K; Nagai K; Kuma K; Nakagawa T
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1097-100. PubMed ID: 2470772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases.
    Tanemoto M; Miyakawa H; Hanai J; Yago M; Kitaoka M; Uchida S
    Am J Kidney Dis; 1995 Nov; 26(5):774-80. PubMed ID: 7485130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.